Malignant T Cell and Other Non-Hodgkin’s Lymphoma

  • M. D. Amylon
  • M. P. Link
  • S. B. Murphy
Part of the UICC International Union Against Cancer book series (1360)


Lymphoma is the third most common malignant diagnosis in children, following acute leukaemia and brain tumours. The incidence is 16.8 per million population in United States white children under 15 years of age. About 45% of these children have Hodgkin’s lymphoma, which is discussed elsewhere. The remaining 55% have any of a diverse group of diagnoses collectively referred to as non-Hodgkin’s lymphoma (NHL) [1]. Included in this group are several histopathologically distinct entities, which have quite variable biological properties. It is perhaps not surprising, therefore, that the natural history and response to therapy of children diagnosed with NHL have been difficult to characterize. There are some generalizations, however, which are worth noting; and recent progress has advanced our understanding of these disorders considerably.


Malignant Lymphoma Acute Lymphoblastic Leukaemia Bone Marrow Involvement Lymphoblastic Lymphoma Structural Core Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Young JL Jr, Miller RW (1975) Incidence of malignant tumors in US children. J Pediatr 86: 254–258PubMedCrossRefGoogle Scholar
  2. 2.
    Lennert K (1978) Classification of non-Hodgkin’s lymphomas. In: Lennert K (ed) Malignant lymphomas other than Hodgkin’s disease. Springer, Berlin Heidelberg New York, pp 83–110Google Scholar
  3. 3.
    Winberg CD, Nathwani BN, Bearman RM, Rappaport H (1981) Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer 48: 2223–2235PubMedCrossRefGoogle Scholar
  4. 4.
    Nathwani B, Kim H, Rappaport H, Solomon J, Fox M (1978) Non-Hodgkin’s lymphomas —A clinic-pathologic study comparing two classifications. Cancer 41: 303–325PubMedCrossRefGoogle Scholar
  5. 5.
    The Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non- Hodgkin’s lymphoma. Summary and description of a working formulation for clinical usage. Cancer 49: 2112–2135.CrossRefGoogle Scholar
  6. 6.
    Berard CW, Jaffe ES, Braylan RC, Mann RB, Nanba K (1978) Immunologic aspects and pathology of the malignant lymphomas. Cancer 42: 911–921PubMedCrossRefGoogle Scholar
  7. 7.
    Wilson JF, Jenkin RDT, Anderson JR, Chilcote RR, Coccia P, Exelby PR, Kersey J, Kjeldsberg CR, Kushner J, Meadows A, Sheehan WW, Siegel S, Sposto R, Leikin S, Hammond D (1984) Studies on the pathology of non-Hodgkin’s lymphoma of childhood. The role of routine histopathology as a prognostic factor. A report from the Children’s Cancer Study Group. Cancer 53: 1695–1704PubMedCrossRefGoogle Scholar
  8. 8.
    Murphy SB, Hustu HO (1980) A randomized trial of combined modality therapy of childhood non- Hodgkin’s lymphoma. Cancer 45: 630–637PubMedCrossRefGoogle Scholar
  9. 9.
    Anderson JR, Wilson JF, Jenkin RDT, Meadows AT, Kersey J, Chilcote RR, Coccia P, Exelby P, Kushner J, Siegal S, Hammond D (1983) Childhood non-Hodgkin’s lymphoma: the results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 308: 559–565PubMedCrossRefGoogle Scholar
  10. 10.
    Sullivan MP, Boyett J, Pullen J, Crist W, Doering EJ, Trueworthy R, Hvizdala E, Ruymann F, Steuber CP (1985) Pediatric oncology group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin’s lymphoma ( Burkitt’s lymphoma excluded ). Cancer 55: 323–336PubMedCrossRefGoogle Scholar
  11. 11.
    Pinkel D, Johnson W, Aur RJA (1975) Non- Hodgkin’s lymphoma in children. Br J Cancer (Suppl) 31: 298–323Google Scholar
  12. 12.
    Jaffe ES, Braylan RC, Frank MM, Green I, Berard CW (1977) Functional markers: a new perspective on malignant lymphomas. Cancer Treat Rep 61: 957–962Google Scholar
  13. 13.
    Lukes RJ (1978) Functional classification of malig-nant lymphoma of Lukes and Collins. In: Mathe G, Seligmann M, Tubiana M (eds) Lymphoid neoplasias I. Classification, categorization, natural history. Springer, Berlin Heidelberg New York, pp 19–30Google Scholar
  14. 14.
    Hardy WD Jr (1978) Epidemiology of primary neoplasms of lymphoid tissues in animals. In: Twomey JJ, Good RA (eds) The immunopathology of lymphoreticular neoplasms. Plenum, New York, pp 129–180CrossRefGoogle Scholar
  15. 15.
    Gallo RC, Todaro GJ (1976) Oncogenic RNA viruses. Semin Oncol 3: 81–95PubMedGoogle Scholar
  16. 16.
    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415–7419PubMedCrossRefGoogle Scholar
  17. 17.
    Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC (1981) Isolation of a new type C retrovirus ( HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature 294: 268–271PubMedCrossRefGoogle Scholar
  18. 18.
    Rho HM, Poiesz B, Ruscetti FW, Gallo RC (1981) Characterization of the reverse transcriptase from a new retrovirus ( HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology 112: 355–360PubMedCrossRefGoogle Scholar
  19. 19.
    Kalyanaraman VS, Sarngadharan MG, Bunn PA, Minna JD, Gallo RC (1981) Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature 294: 271–273PubMedCrossRefGoogle Scholar
  20. 20.
    Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC (1982) Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci USA 79: 1653–1657PubMedCrossRefGoogle Scholar
  21. 21.
    Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T-lymphocytes from normal human bone marrows. Science 193: 1007–1008PubMedCrossRefGoogle Scholar
  22. 22.
    Ruscetti FW, Morgan DA, Gallo RC (1977) Functional and morphologic characterization of human T-cells continuously grown in vitro. J Immunol 119: 131–138PubMedGoogle Scholar
  23. 23.
    Robb RJ, Munck A, Smith KA (1981) T-cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med 154: 1455–1474PubMedCrossRefGoogle Scholar
  24. 24.
    Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC (1983) Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci USA 80: 6957–6961PubMedCrossRefGoogle Scholar
  25. 25.
    Depper JM, Leonard WJ, Robb RJ, Waldmann TA, Greene WC (1983) Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J Immunol 13: 690–696Google Scholar
  26. 26.
    Tsudo M, Uchiyama T, Uchino H, Yodoi J (1983) Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody. Blood 61: 1014–1016PubMedGoogle Scholar
  27. 27.
    Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldmann TA, Green WC. (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311: 626–631PubMedCrossRefGoogle Scholar
  28. 28.
    Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T (1984) Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311: 631–635PubMedCrossRefGoogle Scholar
  29. 29.
    Rowley JD (1983) Human oncogene locations and chromosome aberrations. Nature 301: 290–291PubMedCrossRefGoogle Scholar
  30. 30.
    Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226: 1199–1204PubMedCrossRefGoogle Scholar
  31. 31.
    Hecht F, Morgan R, Hecht BK, Smith SD (1984) Common region on chromosome 14 in T-cell leukemia and lymphoma. Science 226: 1445–1447PubMedCrossRefGoogle Scholar
  32. 32.
    Williams DL, Look AT, Melvin SL, Roberson PK, Dahl G, Flake T, Stass S (1984) New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 36: 101–109PubMedCrossRefGoogle Scholar
  33. 33.
    Ueshima Y, Rowley JD, Variakojis D, Winter J, Gordon L (1984) Cytogenetic studies on patients with chronic T-cell leukemia/lymphoma. Blood 63: 1028–1038PubMedGoogle Scholar
  34. 34.
    Croce CM, Isobe M, Palumbo A, Puck J, Ming J, Tweardly D, Erikson J, Davis M, Rovera G (1985) Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science 227: 1044–1047PubMedCrossRefGoogle Scholar
  35. 35.
    Kaiser-McCaw B, Hecht F (1983) Ataxiatelangiectasia: a cellular and molecular link between cancer, neuropathology and immune deficiency. In: German J (ed) Chromosome mutation on neoplasia. Liss, New York, pp 193–202Google Scholar
  36. 36.
    Barcos MP, Lukes RJ (1975) Malignant lymphoma of convoluted lymphocytes — a new entity of possible T-cell type. In: Sinks LF, Godden JO (eds) Conflicts in childhood cancer. An evaluation of current management, vol 4. Liss, New York, pp 147–178Google Scholar
  37. 37.
    Murphy SB, Frizzera G, Evans AE (1975) A study of childhood non-Hodgkin’s lymphoma. Cancer 2121–2131Google Scholar
  38. 38.
    McKenna RW, Parkin J, Brunning RD (1979) Morphologic and ultrastructural characteristics of T-cell acute lymphoblastic leukemia. Cancer 44: 1290–1297PubMedCrossRefGoogle Scholar
  39. 39.
    Donion JA, Jaffe ES, Braylan RC (1977) Terminal deoxynucleotidyl transferase activity in malignant lymphomas. N Engl J Med 297: 461–464CrossRefGoogle Scholar
  40. 40.
    Virchow R (1847) Pathologische Physiologie des Bluts: II. Weisses Blut (Leukämie). Virchows Arch 1: 563–572CrossRefGoogle Scholar
  41. 41.
    Weinstein HJ, Cassady JR, Levey R (1983) Long- term results of the APO protocol [vincristine, doxorubicin (adriamycin), and prednisone] for treatment of mediastinal lymphoblastic lymphoma. J Clin Oncol 1: 537–541PubMedGoogle Scholar
  42. 42.
    Reinherz EL, Nadler LM, Sallan SE, Schlossman SF (1979) Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest 64: 392–397PubMedCrossRefGoogle Scholar
  43. 43.
    Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES (1983) Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43: 4486–4490PubMedGoogle Scholar
  44. 44.
    Roper M, Crist WM, Metzgar R, Ragab AH, Smith S, Starling K, Pullen J, Leventhal B, Bartolucci AA, Cooper MD (1983) Monoclonal antibody characte-rization of surface antigens in childhood T-cell lymphoid malignancies. Blood 61: 830–837PubMedGoogle Scholar
  45. 45.
    Gregoire KE, Goldschneider I, Barton RW, Bollum FJ (1979) Ontogeny of terminal deoxynucleotidyl transferase positive cells in lymphohematopoietic tissues of rat and mouse. J Immunol 123: 1347–1352PubMedGoogle Scholar
  46. 46.
    Bernard A, Boumsell L, Reinherz EL, Nadler LM, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman SF (1981) Cell surface characterization of malignant T-cells from lymphoblastic lymphoma using monoclonal antibodies. Blood 57: 1105–1110PubMedGoogle Scholar
  47. 47.
    Wantanabe A, Sullivan MP, Sutow WW, Wilbur JR (1973) Undifferentiated lymphoma, non-Burkitt’s type: meningeal and bone marrow involvement in children. Am J Dis Child 125: 57–61Google Scholar
  48. 48.
    Bernard A, Murphy S, Melvin S, Bowman WP, Caillard J, Lemerle J, Boumsell L (1982) Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 59: 549–554PubMedGoogle Scholar
  49. 49.
    Murphy SB, Melvin SL, Mauer AM (1979) Correlation of tumor cell kinetic studies with surface marker results in childhood non-Hodgkin’s lymphoma. Cancer Res 39: 1534–1538PubMedGoogle Scholar
  50. 50.
    Glatstein E, Kim H, Donaldson SS, Dorfman R, Gribble TJ, Wilbur JR, Rosenberg SA, Kaplan HS (1974) Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer 34: 204–211PubMedCrossRefGoogle Scholar
  51. 51.
    Jenkin RDT, Anderson JR, Chilcote RR, Coccia PF, Exelby PR, Kersey JH, Kushner JH, Meadows AT, Siegel SE, Sposto R, Wilson SF, Hammond GD (1984) The treatment of localized non- Hodgkin’s lymphoma in children: a report from the Children’s Cancer Study Group. J Clin Oncol 2: 88–97PubMedGoogle Scholar
  52. 52.
    Murphy SB, Hustu HO, Rivera G, Berard CW (1983) End results of treating children with localized non-Hodgkin’s lymphomas with a combined modality approach of lessened intensity. J Clin Oncol 1: 326–330PubMedGoogle Scholar
  53. 53.
    Tsokos GC, Balow JE, Spiegel RJ, Magrath IT (1981) Renal and metabolic complications of un-differentiated and lymphoblastic lymphomas. Medicine 60: 218–229PubMedCrossRefGoogle Scholar
  54. 54.
    Jenkin RDT, Sonley MJ (1969) The management of malignant lymphomas in childhood. Neoplasia in childhood. Year Book Medical Publishers, Chicago pp 305–319Google Scholar
  55. 55.
    Lemerle M, Gerard-Merchant R, Sancho H, Schweisguth O (1975) Natural history of non- Hodgkin’s malignant lymphomata in childhood. Br J Cancer 31: 332–336Google Scholar
  56. 56.
    Wollner N, Burchenal JH, Leiberman PH, Exelby P, D’Angio G, Murphy ML (1976) Non-Hodgkin’s lymphoma in children: a comparative study of two modalities of therapy. Cancer 37: 123–134PubMedCrossRefGoogle Scholar
  57. 57.
    Mott MG, Chessels JM, Willoughby MLN, Mann JR, Morris Jones P, Malpas JS, Palmer MK (1984) Adjuvant low dose radiation in childhood T-cell leukemia/lymphoma. Br J Cancer 50: 457–462PubMedCrossRefGoogle Scholar
  58. 58.
    Link M, Roper M, Dorfman R, Crist W, Cooper M, Levy R (1983) Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 61: 838–841PubMedGoogle Scholar
  59. 59.
    Weinstein HJ, Lack EE, Cassady JR (1984) APO therapy for malignant lymphoma of large cell “histocytic” type of childhood: analysis of treatment results for 29 patients. Blood 64: 422–426PubMedGoogle Scholar
  60. 60.
    Spector BD, Perry GS, Good RA, Kersey JH (1978) Immunodeficiency diseases and malignancy. In: Twomey JJ, Good RR (eds) The immunopathology of lymphoreticular neoplasms. Plenum, New York, pp 202–237Google Scholar
  61. 61.
    Doggett RS, Wood GS, Horning S, Levy R, Dorfman RF, Bindl J, Warnke RA (1984) The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 115: 245–252PubMedGoogle Scholar
  62. 62.
    Kim H, Jacobs C, Warnke RA, Dorfman RF (1978) Malignant lymphoma with a high content of epi-thelioid histiocytes — a distinct clinicopathologic entity and a form of so-called “Lennert’s lymphoma”. Cancer 41: 620–635PubMedCrossRefGoogle Scholar
  63. 63.
    Bogomdetz WV, Bernard J, Capron F, Diebold J (1983) T cell origin of Lennert’s lymphoma. Arch Pathol Lab Med 107: 586–588Google Scholar
  64. 64.
    Bunin NJ, Hvizdala E, Link M, Callihan TR, Hustu HO, Wharam M, Warnke RA, Berard CW, Murphy SB (1985) Primary mediastinal non- lymphoblastic lymphomas in children: a clinicopathologic study. J Cl in OncolGoogle Scholar
  65. 65.
    Link M, Warnke R, Finlay J, Amylon M, Miller R, Dilley J, Levy R (1983) A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood 62: 722–728PubMedGoogle Scholar
  66. 66.
    Murphy SB (1977) Prognostic factors and obstacles to cure of childhood non-Hodgkin’s lymphoma. Semin Oncol 4: 265–271PubMedGoogle Scholar
  67. 67.
    Magrath IT, James C, Edwards BK, Spiegel R, Jaffe ES, Berard CW, Miliauskas J, Morris K, Barnwell R (1984) An effective therapy for both undifferentiated (including Burkitt’s) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63: 1102–1111PubMedGoogle Scholar
  68. 68.
    Dahl G, Murphy S, Abromowitch M, Kalwinsky D, Pui CH, Ochs J, Mirro J, Look T, Rivera G (1983) VM-26 plus Ara-C as initial and intermittent treatment for stage III-IV lymphoblastic lymphoma and acute lymphoblastic leukemia with a mediastinal mass. Proceedings of the American society for clinical oncology (abstract 216 )Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • M. D. Amylon
  • M. P. Link
  • S. B. Murphy

There are no affiliations available

Personalised recommendations